| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPRO | Exit | Spero Therapeutics, Inc. | $0 | – | -1,013,438 | -100.0% | -0.19% | – |
| Exit | Dianthus Therapeutics, Inc. | $0 | – | -236,979 | -100.0% | -0.50% | – | |
| Exit | Xilio Therapeutics, Inc. | $0 | – | -2,759,344 | -100.0% | -0.90% | – | |
| AVRO | Exit | AvroBio, Inc. | $0 | – | -4,541,381 | -100.0% | -1.08% | – |
| AKRO | Exit | Akero Therapeutics, Inc. | $0 | – | -359,251 | -100.0% | -2.81% | – |
| IKNA | Exit | Ikena Oncology, Inc. | $0 | – | -5,018,178 | -100.0% | -3.36% | – |
| AVTE | Exit | Aerovate Therapeutics, Inc. | $0 | – | -2,039,249 | -100.0% | -4.29% | – |
| GBIO | Exit | Generation Bio, Co. | $0 | – | -8,279,484 | -100.0% | -4.86% | – |
| Exit | Vigil Neuroscience, Inc. | $0 | – | -5,836,874 | -100.0% | -4.87% | – | |
| REPL | Exit | Replimune Group, Inc. | $0 | – | -2,098,300 | -100.0% | -5.56% | – |
| Exit | Third Harmonic Bio, Inc. | $0 | – | -10,907,859 | -100.0% | -10.80% | – | |
| KYMR | Exit | Kymera Therapeutics, Inc. | $0 | – | -5,858,262 | -100.0% | -12.61% | – |
| DYN | Exit | Dyne Therapeutics, Inc. | $0 | – | -9,885,449 | -100.0% | -13.72% | – |
| DAWN | Exit | Day One Biopharmaceuticals, Inc. | $0 | – | -7,608,394 | -100.0% | -14.46% | – |
| Exit | Disc Medicine, Inc. | $0 | – | -2,745,335 | -100.0% | -19.98% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Kymera Therapeutics, Inc. | 8 | Q3 2023 | 40.1% |
| Day One Biopharmaceuticals, Inc. | 8 | Q3 2023 | 26.8% |
| Dyne Therapeutics, Inc. | 8 | Q3 2023 | 15.4% |
| Replimune Group, Inc. | 8 | Q3 2023 | 9.4% |
| Generation Bio, Co. | 8 | Q3 2023 | 9.1% |
| Aerovate Therapeutics, Inc. | 8 | Q3 2023 | 7.2% |
| Akero Therapeutics, Inc. | 8 | Q3 2023 | 4.3% |
| Ikena Oncology, Inc. | 8 | Q3 2023 | 5.8% |
| Xilio Therapeutics, Inc. | 8 | Q3 2023 | 4.1% |
| AVROBIO INC | 8 | Q3 2023 | 1.6% |
View Atlas Venture Life Science Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-06 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-05-16 |
View Atlas Venture Life Science Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.